(Q45746014)

15 December 2017

title

Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine (English)

1 reference

15 December 2017

0 references

1 reference

1 reference

Cederna JB

1

1 reference

15 December 2017

Klinzman D

series ordinal

2

1 reference

15 December 2017

Stapleton JT

series ordinal

3

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

18

1 reference

15 December 2017

issue

9-10

1 reference

15 December 2017

page(s)

892-898

1 reference

15 December 2017

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Protection against hepatitis A by an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Immunoglobulin prophylaxis for hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Serology and interferon production during the early phase of acute hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Persistent infection of human fibroblasts by hepatitis A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Localization of priming epitope to the C-terminal portion of hepatitis A virus VP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Hepatitis A vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Cell-mediated cytotoxicity in hepatitis A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Liver-derived cytotoxic T cells in hepatitis A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Hepatitis A Outbreak in a Neonatal Intensive Care Unit: Risk Factors for Transmission and Evidence of Prolonged Viral Excretion among Preterm Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Echovirus meningomyeloencephalitis with administration of intrathecal immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

Sensitive assays for hepatitis A antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900342-4

7 January 2021

10.1016/S0264-410X(99)00342-4

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017